Research article · 19 Aug 2022
PerspectivePublished 26 Feb 2022
Neurodevelopmental Framework for Drug Discovery Neurodevelopmental Disorders
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There has been a revolution in genetic findings in neurodevelopmental disorders (NDDs) during the last decade, with several discoveries crucial to understanding their aetiology and pathophysiology. Clinical studies with single-gene disorders like fragile X syndrome show how difficult it is to find new treatment targets in NDDs. Incorporating a developmental viewpoint into the drug development process for NDDs should aid in overcoming some of the present challenges in identifying and evaluating new treatments. This publication summarises the proceedings of the European College of Neuropsychopharmacology's 'New Frontiers Meeting' on neurodevelopmental diseases, which was held in collaboration with the AIMS-2-TRIALS project, which is funded by the Innovative Medicines Initiative. It brought together academic and industrial professionals in developmental genetics, autism, neurodevelopmental disorders, and therapeutic trials, as well as regulators, patient and family organisations, and other stakeholders. From a neurodevelopmental standpoint, the meeting aimed to provide a platform for concentrated exchange on scientific insights, difficulties, and techniques that might be applied to the development of CNS treatments. Multidisciplinary translational consortia that produce basic and clinical research at the same time could be crucial in furthering knowledge in the sector. Although it is commonly agreed that clinical trials for NDDs in children are necessary, safety concerns should influence every aspect of their design. With regulatory backing, industry and academics should collaborate to enhance knowledge of the biology of brain development, determine the ideal timing of interventions, and translate these results into novel pharmaceuticals that meet the requirements of users and families.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Neurodevelopmental Disorders and Treatment.
Perspective · 27 Mar 2022
Behavioral Sleep Intervention for Insomnia in Children with Neurodevelopmental Issues
Editorial · 26 Mar 2022
Neurodevelopmental Disorders and the Cerebellum
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurodevelopmental Disorders and Treatment
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Stephen White”
- BylineArticles whose byline prints “Russell Clark”

